×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SYRE – spyre therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SYRE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/10
04:05 pm
syre
Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026
Low
Report
Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026
4/8
07:30 am
syre
Spyre CEO Sells $740K in Stock After 300% Surge as Key Q3 Data Nears [Yahoo! Finance]
Low
Report
Spyre CEO Sells $740K in Stock After 300% Surge as Key Q3 Data Nears [Yahoo! Finance]
4/3
04:01 pm
syre
Spyre Therapeutics Announces Grants of Inducement Awards
Low
Report
Spyre Therapeutics Announces Grants of Inducement Awards
3/31
08:02 am
syre
Spyre Therapeutics (SYRE) had its "buy" rating reaffirmed by BTIG Research. They now have a $70.00 price target on the stock.
Medium
Report
Spyre Therapeutics (SYRE) had its "buy" rating reaffirmed by BTIG Research. They now have a $70.00 price target on the stock.
3/22
11:50 am
syre
Assessing Spyre Therapeutics (SYRE) Valuation After Strong One Year Return And Premium Price To Book Ratio [Yahoo! Finance]
Low
Report
Assessing Spyre Therapeutics (SYRE) Valuation After Strong One Year Return And Premium Price To Book Ratio [Yahoo! Finance]
3/18
11:00 pm
syre
Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools [Yahoo! Finance]
Low
Report
Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools [Yahoo! Finance]
3/18
01:44 pm
syre
Spyre Therapeutics (SYRE) had its price target raised by Stifel Nicolaus from $70.00 to $92.00. They now have a "buy" rating on the stock.
Low
Report
Spyre Therapeutics (SYRE) had its price target raised by Stifel Nicolaus from $70.00 to $92.00. They now have a "buy" rating on the stock.
3/17
02:21 pm
syre
Spyre: 'Strong Buy' As UC Program Moves Along And Q3 2026 RA Data Looms [Seeking Alpha]
Low
Report
Spyre: 'Strong Buy' As UC Program Moves Along And Q3 2026 RA Data Looms [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/10
04:14 pm
syre
Form ARS Spyre Therapeutics, Inc. For: Dec 31
Low
Report
Form ARS Spyre Therapeutics, Inc. For: Dec 31
4/10
04:05 pm
syre
Form DEFA14A Spyre Therapeutics, Inc.
Low
Report
Form DEFA14A Spyre Therapeutics, Inc.
4/10
04:02 pm
syre
Form DEF 14A Spyre Therapeutics, Inc. For: May 27
Low
Report
Form DEF 14A Spyre Therapeutics, Inc. For: May 27
4/3
09:31 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Apr 01 Filed by: Turtle Cameron
Low
Report
Form 4 Spyre Therapeutics, Inc. For: Apr 01 Filed by: Turtle Cameron
4/3
09:30 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Apr 01 Filed by: Sloan Sheldon
Low
Report
Form 4 Spyre Therapeutics, Inc. For: Apr 01 Filed by: Sloan Sheldon
4/3
09:29 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Apr 01 Filed by: Burrows Scott L
Low
Report
Form 4 Spyre Therapeutics, Inc. For: Apr 01 Filed by: Burrows Scott L
4/1
04:39 pm
syre
Form 144 Spyre Therapeutics, Inc. Filed by: Sloan Sheldon
Low
Report
Form 144 Spyre Therapeutics, Inc. Filed by: Sloan Sheldon
3/27
01:18 pm
syre
Form SCHEDULE 13G/A Spyre Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Spyre Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: